- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01861431
Evaluating a Microfinance Intervention for High Risk Women in Mongolia
The proposed study aims to test the feasibility and preliminary efficacy of a combined 4-session HIV sexual risk reduction (HIVSRR) and microfinance intervention (including 34 training session and matched savings) to reduce unprotected sex and to increase proportion of income from sex work among women engaged in high risk sexual activity in Ulaanbaatar, Mongolia. Feasibility and preliminary efficacy will be tested using a randomized clinical trial (RCT) with 134 women sex workers meeting eligibility criteria. Following eligibility screening, eligible women will complete informed consent, a baseline assessment, and be randomized to one of 2 study conditions: 1) the combination HIV sexual risk reduction plus microfinance (HIVSRR+MF); or 2) a 4-session HIVSRR alone control condition.
The study design will permit us to:
- Examine and enhance the feasibility (i.e. recruitment, engagement, attendance, retention data collection) of a combination HIV sexual risk reduction and MF intervention with high risk women in Ulaanbaatar, Mongolia;
- Examine the preliminary outcomes of the interventions on decreasing unprotected acts of vaginal and anal intercourse; increasing the proportion of protected vaginal and/or anal acts using barrier protection and decreasing number of sexual partners with repeated measures at baseline, immediately post-intervention, and 3 and 6 month follow-up assessments.
- Use the results of the pilot study to inform the design of a future R01 application.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ulaanbaatar,, Mongolia
- Aira Toivgoo, co-PI
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- She is at least 18 years of age;
- She reports having engaged in vaginal or anal sexual intercourse in the past 90 days in exchange for money, alcohol or other goods;
- She reports having engaged in unprotected vaginal or anal sexual intercourse in the past 90 days with a paying sexual partner; and
- She reports being interested in learning about and developing her own small business.
Exclusion Criteria:
- assessed to have a severe cognitive or psychiatric impairment that would interfere with the ability to provide informed consent or complete study instruments
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: HIVSRR
4 sessions of HIV sexual risk reduction
|
4 sessions of HIV sexual risk reduction
|
|
Experimental: HIVSRR + Microfinance
4 sessions of sexual risk reduction plus 12 sessions of financial literacy, 12 sessions of business development training, 10 sessions of business mentorship; matched savings throughout course of intervention
|
4 sessions of sexual risk reduction plus 12 sessions of financial literacy, 12 sessions of business development training, 10 sessions of business mentorship; matched savings throughout course of intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
unprotected acts of vaginal and anal intercourse;
Time Frame: 6 months
|
The primary outcomes include: decreasing unprotected acts of vaginal and anal intercourse; increasing the proportion of protected vaginal and/or anal acts using barrier protection and decreasing number of sexual partners with repeated measures at baseline, immediately post-intervention, and 3 and 6 month follow-up assessments.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
proportion of protected vaginal and/or anal acts using barrier protection;
Time Frame: 6 months
|
6 months
|
|
number of sexual partners
Time Frame: 6 months
|
6 months
|
|
Proportion of income from sex work
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Susan S Witte, PhD, Columbia University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AAAF4402
- R34MH093227 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Infection
-
Federal University of São PauloGilead SciencesCompleted
-
ANRS, Emerging Infectious DiseasesNot yet recruitingAntiretroviral Therapy | HIV-1 Infection | HIV Reservoir
-
Gilead SciencesNot yet recruiting
-
International Maternal Pediatric Adolescent AIDS...National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaboratorsNot yet recruitingHIV -1 InfectionUnited States
-
Fundación HuéspedViiV HealthcareNot yet recruitingHIV-1-infectionArgentina, Brazil
-
Fundación HuéspedMSD Pharmaceuticals LLC; Fundacion IDEAANot yet recruiting
-
Henan Genuine Biotech Co., Ltd.Recruiting
-
Erasmus Medical CenterNot yet recruitingHIV Infections | Hiv | HIV-1-infection | HIV I InfectionNetherlands
-
Sociedad Andaluza de Enfermedades InfecciosasConsejeria de Salud. Junta de Andalucia. SpainCompletedHIV Infection | HIV-1 InfectionSpain
-
Hospital Universitario 12 de OctubreUniversity of Rome Tor Vergata; International AIDS Vaccine Initiative; University... and other collaboratorsNot yet recruiting
Clinical Trials on HIV Sexual Risk reduction
-
US Department of Veterans AffairsCompletedHIV Infections | Immune System Diseases | Delivery of Health Care | Health Care Quality, Access, and EvaluationUnited States
-
University of New MexicoNational Institute on Alcohol Abuse and Alcoholism (NIAAA)WithdrawnDrinking Behavior | Sexual Behavior | Health Behavior | Adolescent Behavior | Risk Reduction BehaviorUnited States
-
University of MiamiNational Institute of Mental Health (NIMH)Completed
-
University of New MexicoWithdrawnAlcohol Use | Drug Use | Sexual Risk BehaviorUnited States
-
Massachusetts General HospitalUniversity of Miami; Fenway Community HealthCompletedStress Disorders, Post-Traumatic | Sexual Risk Behavior | Childhood Sexual AbuseUnited States
-
University of PennsylvaniaNational Institute on Minority Health and Health Disparities (NIMHD)CompletedHuman Immunodeficiency Virus (HIV) | Sexually Transmitted Disease (STD)United States
-
Emory UniversityAmerican University of ArmeniaCompletedHIV Infections | HIV PreventionArmenia
-
Michele StatonNational Institute on Drug Abuse (NIDA)CompletedHepatitis C | Drug Abuse | Acquired Immune Deficiency Syndrome VirusUnited States
-
University of New MexicoNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedCannabis | Sexual Behavior | Health Behavior | Adolescent Behavior | Risk Reduction BehaviorUnited States
-
Hunter College of City University of New YorkCompletedSubstance Use | Sexual RiskUnited States